Skip to main content

KWS SAAT Licenses Genome Engineering Technology from Two Blades

NEW YORK (GenomeWeb News) – The Two Blades Foundation today said it has completed a non-exclusive licensing agreement with KWS SAAT covering Two Blades' Transcription Activator Like effector code technology for genome engineering in certain crops.

The technology is for making specific changes in genomes based on novel sequence-specific DNA-binding proteins. TAL effector proteins can be designed to recognize almost any DNA sequence of interest and specific locations in the genome can be targeted for gene replacement and gene function modulation.

Two Blades holds exclusive rights to the technology in plants. The TAL Code technology was discovered by researchers at Martin-Luther University in Halle, Germany.

Financial and other terms of the deal were not disclosed.

Two Blades reached similar deals earlier this year for the TAL Code technology with Bayer CropScience, Monsanto, and Syngenta. The not-for-profit corporation, based in Evanston, Ill., develops durable disease resistance in agricultural crops.

KWS SAAT is a plant breeding firm based in Einbeck, Germany.

The Scan

Response Too Slow, Cautious

A new report criticizes the global response to the threat of the COVID-19 pandemic, Nature News reports.

Pushed a Bit Later

Novavax has pushed back its timeline for filing for authorization for its SARS-CoV-2 vaccine, according to Bloomberg.

AMA Announces Anti-Racism Effort

The Associated Press reports that the American Medical Association has released a plan to address systemic racism in healthcare.

Nucleic Acids Research Papers on miRMaster 2.0, MutationTaster2021, LipidSuite

In Nucleic Acids Research this week: tool to examine small non-coding RNAs, approach to predict ramifications of DNA variants, and more.